InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP

events
Press-Release
Conference
October 2, 2025

InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces their participation in BioTechX Europe 2025 which is to be held from October 6-8, 2025 at Messe Basel, Switzerland.

Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, and Igor Goryanin, Professor at University of Edinburgh, will host a roundtable discussion entitled, "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges" on October 6, 10:40 a.m. CET. This discussion will explore how AI can be integrated into QSP workflows. It will highlight key opportunities for AI to enhance QSP models, address challenges related to interpretability, and outline future directions for broader adoption in pharma, biotech, and precision medicine.

In addition to the roundtable discussion, InSysBio is going to present their modeling services for drug research and development in frames of the exhibition.

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

September 2025
MoTuWeThFrSaSu
1
2
3
4
5
6
7
8
9
10
1. 10 Sep 2025 15:18 InSysBio to participate in ACoP 2025 InSysBio announces its participation in 2025 American Conference on Pharmacometrics (ACoP 2025) which is to be held from October 18-21, 2025 at the Gaylord Rockies, Aurora, Colorado, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 2 posters in frames of the Conference
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
1. 25 Sep 2025 14:12 InSysBio to take part in BioTechX Europe 2025 InSysBio announces its participation in BioTechX Europe 2025 on 6–8 October 2025 at Messe Basel, Switzerland. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, is going to present InSysBio's modeling services for drug research & development at the Booth S62
26
27
28
29
30
1. 30 Sep 2025 16:17 InSysBio to participate in JuliaCon Local Paris 2025 InSysBio announces its participation in JuliaCon Local Paris 2025 which is to be held from October 2-3, 2025 at the National Conservatory of Arts and Crafts, Paris, France. Ivan Borisov, Senior Software Developer at InSysBio, will present a poster in frames of the Conference
     
Upcoming Events
18.10
InSysBio to participate in ACoP 2025
06.10
InSysBio to take part in BioTechX Europe 2025
02.10
InSysBio to participate in JuliaCon Local Paris 2025
06.10
InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP
Tags
Latest News
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling